Send me a link:

*Text messaging rates may apply.

 Dow Down 0.77% Nasdaq Down 0.79%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.71 Down 0.06(1.26%) 9:36AM EDT - Nasdaq Real Time Price
Prev Close:4.77
Open:N/A
Bid:4.68 x 500
Ask:4.85 x 1000
1y Target Est:7.83
Beta:-2.36
Earnings Date:Jul 31 - Aug 1 (Est.)
Day's Range:4.70 - 4.75
52wk Range:4.05 - 7.97
Volume:62,470
Avg Vol (3m):5,339,300
Market Cap:1.03B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNADown 1.26%1.03B
GSKUp 0.58%117.10B
OREXDown 0.79%586.29M
RHHBY 0.00%250.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.43
Quarterly EPS Est (Jun-14) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback